Vidhi Specialty Food Ingredients Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹99Cr
- +57.1% YoY
- +8.8% QoQ
- Net profit
- ₹13Cr
- +44.4% YoY
- +30% QoQ
- Margin
- 19%
- −4 pp YoY
- +2 pp QoQ
Guidance rank: #35 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Vidhi Specialty Food Ingredients Ltd's Q3 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q3 FY25 Revenue from Operations: Rs. 98.5 Crs. Q3 FY25 EBITDA: Rs. 19.0 Crs, up 31.8% YoY (from Rs. 14.4 Crs in Q3 FY24).
From Vidhi Specialty Food Ingredients Ltd's Q3 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q3 FY25 Revenue from Operations: Rs. 98.5 Crs
- Q3 FY24 Revenue from Operations: Rs. 63.0 Crs
- Year-on-Year (Y-o-Y) Growth: 56.5% increase
- 9MFY25 Revenue: Rs. 272.8 Crs vs Rs. 222.8 Crs in 9MFY24 (22.4% Y-o-Y growth)
2 more points from Vidhi Specialty Food Ingredients Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Vidhi Specialty Food Ingredients Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Dahej SEZ Plant (Phase-I)
- Capacity added: 350 MT per month, increasing total to 675 MT
- Commercial production commenced December 12, 2023 (trial started August 27, 2023)
- Investment: INR 70 Crs funded through internal accruals
- Status: Operational with some teething issues; expected to run at optimal capacity before financial year-end
- Roha MIDC Plant (Phase-II) - Arjun Foods (wholly-owned subsidiary)
- Planned capacity addition: 360 MT per month (180 MT per phase)
- Environmental clearance applied
- Location: 200 meters from current Roha manufacturing site
- Expected timeline: 2025-26
- Overall Capacity Expansion Plan
2 more points from Vidhi Specialty Food Ingredients Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vidhi Specialty Food Ingredients Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Vidhi Specialty Food Ingredients Ltd said on order book & pipeline — free account, 30 seconds.
Vidhi Specialty Food Ingredients Ltd — Quarterly revenue & net profit
Vidhi Specialty Food Ingredients Ltd Q3 FY25 results — key figures
| ₹ Cr | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 99 | 63 | +57.1% | 91 | +8.8% |
| Operating profit (EBITDA) | 19 | 14 | +35.7% | 15 | +26.7% |
| Operating margin | 19% | 23% | -4 pp | 17% | +2 pp |
| Profit before tax | 17 | 12 | +41.7% | 14 | +21.4% |
| Net profit (PAT) | 13 | 9 | +44.4% | 10 | +30% |
| EPS (₹) | 2.54 | 1.71 | +48.5% | 2.08 | +22.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹137 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vidhi Specialty's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q4 FY24 earnings call →
Earlier calls (1)
Others in Chemicals & Petrochemicals this season
- Himadri Special (Q3 FY25)
1,131.81 Crs, up 7.53% YoY (from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Gujarat Alkalies (Q3 FY25)
3,702.77 Crores (up from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Balaji Amines (Q3 FY25)
Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key concall takeaways from Balaji Amines Ltd's Q3…
- Chemcon Speciality Chemicals (Q3 FY25)
54.4 Cr, up 3% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Vidhi Specialty Food Ingredients Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vidhi Specialty Food Ingredients Ltd Q3 FY25 results?
Q3 FY25 Revenue from Operations: Rs. 98.5 Crs. Q3 FY25 EBITDA: Rs. 19.0 Crs, up 31.8% YoY (from Rs. 14.4 Crs in Q3 FY24).
What is Vidhi Specialty Food Ingredients Ltd share price analysis?
Vidhi Specialty Food Ingredients Ltd currently shows a neutral. The stock trades at a P/E of 32.1 with a market cap of ₹1,721 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vidhi Specialty Food Ingredients Ltd planning capital expenditure?
Dahej SEZ Plant (Phase-I) - Capacity added: 350 MT per month, increasing total to 675 MT - Commercial production commenced December 12, 2023 (trial started August 27, 2023) - Investment:
Keep Vidhi Specialty Food Ingredients Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
